Hadimeri H, Johansson A C, Haraldsson B, Nyberg G
Department of Nephrology, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden.
Perit Dial Int. 1998 Jul-Aug;18(4):429-32.
To investigate whether there are specific complications to continuous ambulatory peritoneal dialysis (CAPD) in patients with autosomal dominant polycystic kidney disease (ADPKD) due to defects in various wall structures--causing hernia and diverticulitis--and to enlarged kidneys.
The clinical experience of CAPD in 26 patients with ADPKD, treated for 11+/-6 months, was studied in retrospect and compared with that of 26 contemporary controls. Medical records were reviewed with respect to survival in this treatment form and any complication. Peritoneal dialysis capacity (PDC), as measured in 21 ADPKD patients and 20 controls, was also evaluated.
University Hospital.
Before initiation of CAPD, enlarged kidneys necessitated nephrectomy in 2 of 26 ADPKD patients; both cases were registered as preparation for transplantation, not for CAPD. Survival in CAPD was similar in ADPKD patients and controls. Hernia was present in 4 ADPKD patients and 2 controls, and required transfer to hemodialysis in 1 patient from each group, temporarily. The incidence of peritonitis was 1 per 20 months in ADPKD patients versus 1 in 27 months in the controls, not significantly different. Peritonitis was caused by colonic bacteria in similar numbers. Residual renal function was 1.9 2.1 mL/min per 1.73 m2 in ADPKD patients versus 1.9+/-1.4 mL/min per 1.73 m2 in the controls. No difference was detected in any of the variables measured by PDC.
There were no specific problems related to ADPKD.
研究常染色体显性遗传性多囊肾病(ADPKD)患者进行持续性非卧床腹膜透析(CAPD)时,是否因各种壁结构缺陷(导致疝和憩室炎)及肾脏增大而出现特定并发症。
回顾性研究26例接受CAPD治疗11±6个月的ADPKD患者的临床经验,并与26例同期对照者进行比较。查阅医疗记录,了解这种治疗方式下的生存率及任何并发症情况。还评估了21例ADPKD患者和20例对照者的腹膜透析能力(PDC)。
大学医院。
在开始CAPD之前,26例ADPKD患者中有2例因肾脏增大需要进行肾切除术;这两例均登记为移植准备,而非CAPD准备。ADPKD患者和对照者在CAPD中的生存率相似。4例ADPKD患者和2例对照者出现疝,每组各有1例患者需要暂时转为血液透析。ADPKD患者腹膜炎发生率为每20个月1次,对照者为每27个月1次,差异无统计学意义。由结肠细菌引起的腹膜炎数量相似。ADPKD患者每1.73平方米的残余肾功能为1.9±2.1毫升/分钟,对照者为1.9±1.4毫升/分钟。PDC测量的任何变量均未检测到差异。
与ADPKD无关的特定问题不存在。